Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
120.94
+0.20 (0.17%)
At close: Oct 24, 2025, 4:00 PM EDT
121.00
+0.06 (0.05%)
After-hours: Oct 24, 2025, 7:45 PM EDT
Gilead Sciences Stock Forecast
Stock Price Forecast
The 21 analysts that cover Gilead Sciences stock have a consensus rating of "Buy" and an average price target of $118.76, which forecasts a -1.80% decrease in the stock price over the next year. The lowest target is $80 and the highest is $145.
Price Target: $118.76 (-1.80%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Gilead Sciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 5 | 5 | 6 |
| Buy | 13 | 13 | 12 | 12 | 12 | 10 |
| Hold | 9 | 9 | 8 | 7 | 6 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 25 | 25 | 24 | 24 | 23 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy Maintains $115 → $125 | Strong Buy | Maintains | $115 → $125 | +3.36% | Oct 23, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $125 → $135 | Strong Buy | Maintains | $125 → $135 | +11.63% | Oct 8, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $135 → $145 | Buy | Maintains | $135 → $145 | +19.89% | Sep 16, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $96 → $98 | Hold | Maintains | $96 → $98 | -18.97% | Aug 8, 2025 |
| UBS | UBS | Hold Maintains $108 → $112 | Hold | Maintains | $108 → $112 | -7.39% | Aug 8, 2025 |
Financial Forecast
Revenue This Year
29.40B
from 28.75B
Increased by 2.25%
Revenue Next Year
30.51B
from 29.40B
Increased by 3.77%
EPS This Year
8.19
from 0.38
Increased by 2,056.22%
EPS Next Year
8.77
from 8.19
Increased by 7.06%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 30.8B | 32.5B | |||
| Avg | 29.4B | 30.5B | |||
| Low | 27.9B | 28.1B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 7.1% | 10.5% | |||
| Avg | 2.3% | 3.8% | |||
| Low | -2.8% | -4.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 8.75 | 9.96 | |||
| Avg | 8.19 | 8.77 | |||
| Low | 7.59 | 6.29 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2,201.7% | 21.6% | |||
| Avg | 2,056.2% | 7.1% | |||
| Low | 1,896.1% | -23.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.